Blockchain

Forgd is Reinventing Web3 Advisory with Free Tools for Tokenomics Design, Liquidity Monitoring, and Token Cap Table Management

on

    More in Blockchain:

    New York, NY, September 3rd, 2024, Chainwire

    Forgd, a token advisory and optimization platform, announced the launch of its free-to-use web platform, which provides blockchain projects unrestricted access to tools for tokenomics design, liquidity monitoring, cap table management, and financial planning. Forgd eliminates financial barriers associated with traditional Web3 Advisory and consolidates an otherwise fragmented services industry built to support blockchain projects as they issue a token.

    A token launch involves complex challenges, prompting many blockchain projects to hire multiple external advisors for tasks like tokenomics modeling, market maker engagement, and exchange listing. These engagements can be costly and often lead to operational inefficiencies, given that few advisors operate an end-to-end process. Forgd addresses these challenges with free software tools for executing all vital go-to-market activities and optimizing token performance post-launch. This “self-service” approach to Web3 advisory allows teams to execute at their own pace.

    “Many of the tasks involved in a token launch are outside the expertise of a typical tech founder, which is why we created a set of tools to streamline and simplify the process in an end-to-end application,” said Shane Molidor, CEO and Founder of Forgd. “Forgd was built in response to the recurring needs of founders we’ve observed in Web3. Our DIY software tools not only reduce costs but also allow teams to concentrate on product innovation rather than specialized capital market activities.”

    Shane Molidor is a 10-year cryptocurrency veteran who formerly operated as CEO of AscendEX, Head of Trading at FBG Capital, and Business Development Associate at Gemini. Forgd recently enhanced its capabilities by acquiring Tokenomics DAO, a research institution focused on tokenomics and novel protocol design. 

    For blockchain projects that haven’t yet launched their token, Forgd helps them design tokenomics, conduct cash flow analysis & prepare for fundraising, secure partnerships with market makers & exchanges, and navigate administrative tasks such as offshore company formation. For projects with a live token, Forgd provides tools for monitoring market maker performance & token unlocks, automated token streaming, and even non-custodial liquidity provision.

    In a strategic move, Forgd has aligned with the Solana Foundation to provide select tools exclusively for projects built on the Solana blockchain. This collaboration underscores the Forgd commitment to supporting scalable blockchain ecosystems and fostering project growth.

    “We are thrilled to collaborate with the Solana Foundation to offer our tools to Solana’s vibrant developer ecosystem,” said Florian Strauf, CTO of Forgd and Founder of Tokenomics DAO. “This strategic alignment highlights our dedication to creating public goods to support blockchain entrepreneurs, and we look forward to partnering with other blockchain base layers to create comprehensive cross-chain support.”

    Forgd reports that over 250 projects have already benefited from using its pioneering tools, such as “AMM²”, a non-custodial market making protocol that empowers projects to act as their liquidity provider across all major exchanges with automated rebalancing.

    “The positive response since our private beta launch in Q1’24 has been overwhelming,” commented Shane Molidor. “Our team is motivated to continue innovating and developing new tools to empower Web3 entrepreneurs aiming to launch and scale projects of their own.”

    For more information about Forgd and its services, users can visit Forgd.com.

    About Forgd:

    Forgd is a token advisory and optimization platform with free software tools for blockchain founders to launch and scale their projects.

    Operating as a public good, Forgd is reinventing Web3 advisory by providing blockchain projects free access to specialized capital markets tools such as tokenomics modeling, liquidity monitoring, cap table management, exchange listing, and financial planning. In addition to its self-service software tools, Forgd offers tailored consulting services for teams seeking extra guidance. This approach allows Forgd to service a broad spectrum of blockchain projects ranging from DIY enthusiasts to those who prefer white-glove support, ensuring accessibility and expert assistance are readily available.

    www.x.com/forgd_

    Contact

    Marketing
    Dan Mulligan
    Forgd
    dan@forgd.com

    PostAd_coinrule_banner728x90

    Leave a Comment

    Your email address will not be published. Required fields are marked *

    *

    Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

    2024-09-17T13:00:00Z

    Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

    AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which RenovaroCube is based.

    Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

    Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

    RenovaroCube's AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

    The initial aim is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

    In their analysis, PersonalAIze noted the platform's focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

    Based on these findings, PersonalAIze is eager to collaborate further with RenovaroCube to enhance and commercialize the platform.

    PersonalAIze aims to contribute in several key areas:

    • Advancing AI models by leveraging the latest state-of-the-art techniques.
    • Supporting the professional growth of the software team.
    • Enhancing the explainability of AI models, engaging clinicians in model development.
    • Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

    This partnership could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

    About Renovaro
    Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

    RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

    About PersonalAIze
    PersonalAIze focusses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision making systems as well as improvement of health care operations such as capacity planning.

    Forward-Looking Statements

    Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

    For media inquiries, please contact: karen@renovarocube.com

    Source: Renovaro Inc.


    GlobeNewsWire News

    Recent Comments